开始
RocketTickers

PTGX Announces Fast Track Designation by U.S. FDA

做多
Protagonist Therapeutics, Inc. (NASDAQ:PTGX)  
RocketTickers  
NASDAQ:PTGX   Protagonist Therapeutics, Inc.
Beyond Technical Analysis
2
0
beyondta
Protagonist Therapeutics Announces Fast Track Designation Granted by U.S. FDA to Hepcidin Mimetic PTG-300
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。